532 related articles for article (PubMed ID: 1696012)
1. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
Graham GJ; Maio JJ
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
[TBL] [Abstract][Full Text] [Related]
2. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.
Lisziewicz J; Rappaport J; Dhar R
New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of heterologous promoters by HIV-1 tat.
Han P; Brown R; Barsoum J
Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
[TBL] [Abstract][Full Text] [Related]
4. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
5. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
Southgate C; Zapp ML; Green MR
Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
[TBL] [Abstract][Full Text] [Related]
6. Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure.
Berkhout B; Gatignol A; Silver J; Jeang KT
Nucleic Acids Res; 1990 Apr; 18(7):1839-46. PubMed ID: 2186367
[TBL] [Abstract][Full Text] [Related]
7. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
Robinson D; Elliott JF; Chang LJ
Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
9. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
[TBL] [Abstract][Full Text] [Related]
10. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication.
Harrich D; Mavankal G; Mette-Snider A; Gaynor RB
J Virol; 1995 Aug; 69(8):4906-13. PubMed ID: 7609059
[TBL] [Abstract][Full Text] [Related]
12. Tat trans-activates the human immunodeficiency virus through a nascent RNA target.
Berkhout B; Silverman RH; Jeang KT
Cell; 1989 Oct; 59(2):273-82. PubMed ID: 2478293
[TBL] [Abstract][Full Text] [Related]
13. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS; Madore SJ; Malim MH; Cullen BR
Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
[TBL] [Abstract][Full Text] [Related]
14. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription.
Churcher MJ; Lowe AD; Gait MJ; Karn J
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2408-12. PubMed ID: 7892280
[TBL] [Abstract][Full Text] [Related]
15. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
Roebuck KA; Rabbi MF; Kagnoff MF
AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
[TBL] [Abstract][Full Text] [Related]
18. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
Tao J; Frankel AD
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
[TBL] [Abstract][Full Text] [Related]
19. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease.
Jayasena SD; Johnston BH
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.
Luo Y; Madore SJ; Parslow TG; Cullen BR; Peterlin BM
J Virol; 1993 Sep; 67(9):5617-22. PubMed ID: 8350414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
